r.frisk
TL2 Moderator · Odense
Contributes reviews on supplier material. Based in Odense.
Joined 1 April 2025 · last posted 1d
76 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #113 · Analytics › COA interpretation · 27 Jul 2026 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #75 · Outcomes › Body composition · 25 Jul 2026 · 9 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Here for the analytics and not much else Replied, post #83 · Lounge › Introductions · 24 Jul 2026 · 0 likes I read post #81 twice before replying, because I had assumed the opposite. No judgment: people come to this community from all backgrounds and with all motivations.…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #44 · Sourcing › Regulatory · 20 Jul 2026 · 31 likes post #43 answers the question as asked. The question underneath it is different. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #76 · Outcomes › Progress reports · 16 Jul 2026 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Alcohol: what is documented and what is folklore Replied, post #112 · Practice › Interactions · 15 Jul 2026 · 5 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Athletes in weight-category sports: a different risk calculus Replied, post #23 · Clinical › Special populations · 13 Jul 2026 · 1 like Worth separating two things that post #19 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #93 · Data & Tools › Datasets · 9 Jul 2026 · 2 likes Worth separating two things that post #89 runs together. Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone…
-
Research-use-only status: what it means legally and practically Replied, post #66 · Compounds › Other compounds · 29 Jun 2026 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #31 · Practice › Reconstitution · 23 Jun 2026 · 0 likes Coming back to post #29, because the follow-up matters more than the original answer. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL…
-
Tracking a shortage from primary sources rather than rumour Replied, post #58 · Access › Shortages · 19 Jun 2026 · 25 likes Worth separating two things that post #54 runs together. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #75 · Practice › Storage & stability · 7 Jun 2026 · 3 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Injection volume, overload, and peak distortion Replied, post #33 · Analytics › HPLC & UHPLC · 3 Jun 2026 · 26 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #22 · Compounds › Semaglutide · 18 May 2026 · 1 like The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Packaging that arrived damaged: documenting it properly Replied, post #9 · Sourcing › Logistics · 13 May 2026 · 5 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Reading a home test result without over-claiming Replied, post #39 · Analytics › Home & field testing · 11 May 2026 · 22 likes post #38 answers the question as asked. The question underneath it is different. What physical quantity does the device measure? A colorimetric or lateral-flow method…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #43 · Evidence › Preprints · 1 May 2026 · 18 likes This follows post #40 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #87 · Clinical › Bloodwork · 26 Apr 2026 · 24 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Step therapy requirements and how to satisfy them Replied, post #5 · Access › Insurance & coverage · 22 Apr 2026 · 15 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #89 · Analytics › Mass spectrometry · 31 Mar 2026 · 13 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #111 · Research Methods › N-of-1 designs · 27 Mar 2026 · 0 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #41 · Evidence › Trials · 23 Mar 2026 · 0 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #14 · Evidence › Journal club · 22 Mar 2026 · 18 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #64 · Clinical › Bloodwork · 14 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The lowest dose that does anything: is that a real question? Replied, post #36 · Practice › Dosing & titration · 3 Mar 2026 · 8 likes This follows post #33 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
-
Five questions in one post gets you one answer — how to split them Replied, post #20 · Start Here › How to Ask · 26 Feb 2026 · 26 likes post #19 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
A calculator that gives a right answer to the wrong question Replied, post #7 · Data & Tools › Calculators · 26 Feb 2026 · 0 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #77 · Analytics › Impurities & related substances · 20 Feb 2026 · 0 likes Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #69 · Practice › Storage & stability · 20 Feb 2026 · 4 likes Coming back to post #67, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #54 · Sourcing › Red flags · 18 Jan 2026 · 0 likes Worth separating two things that post #50 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A parcel stationary at a customs facility for nine days Replied, post #13 · Sourcing › Logistics · 19 Dec 2025 · 15 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Documentation that appears only after payment Replied, post #102 · Sourcing › Red flags · 10 Dec 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Tracking a preprint to publication: a worked example Replied, post #27 · Evidence › Preprints · 2 Dec 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #66 · Compounds › Oral incretins · 29 Nov 2025 · 0 likes post #65 answers the question as asked. The question underneath it is different. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Second pass at: Programming during a large energy deficit Replied, post #88 · Nutrition & Training › Resistance training · 19 Nov 2025 · 2 likes Worth separating two things that post #84 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Substitution between formats during a shortage Replied, post #97 · Access › Shortages · 17 Nov 2025 · 2 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
EMA product information as a primary source Replied, post #49 · Regional › European Union · 9 Nov 2025 · 0 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #14 · Compounds › Tirzepatide · 7 Nov 2025 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #2 · Practice › Interactions · 31 Oct 2025 · 21 likes I read the opening post twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D,…
-
A 40-week log with the measurement method stated Replied, post #75 · Outcomes › Progress reports · 26 Oct 2025 · 8 likes Coming back to post #73, because the follow-up matters more than the original answer. Seasonal patterns: some people report weight loss is slower in winter than summer.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #42 · Safety › Adverse events · 21 Oct 2025 · 1 like I read post #40 twice before replying, because I had assumed the opposite. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain,…
-
Cross-border purchase rules within the EU Replied, post #27 · Regional › European Union · 21 Oct 2025 · 0 likes This follows post #24 rather than contradicting it. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management…
-
Documentation that appears only after payment Replied, post #46 · Sourcing › Red flags · 11 Oct 2025 · 0 likes This follows post #43 rather than contradicting it. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #77 · Evidence › Journal club · 11 Oct 2025 · 8 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
How to read a forest plot, properly, from scratch Replied, post #35 · Evidence › Trials · 2 Oct 2025 · 6 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Managing an unplanned gap in supply — what changed since Replied, post #76 · Access › Shortages · 1 Oct 2025 · 3 likes Picking up post #73: that is the part I would want checked first. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages.…
-
Thyroid function tests during substantial weight change Replied, post #64 · Clinical › Bloodwork · 17 Sep 2025 · 11 likes On post #60 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Comparing two chromatograms from different laboratories, properly Replied, post #6 · Analytics › HPLC & UHPLC · 27 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What a 2 ppm match establishes, and what it does not Replied, post #43 · Analytics › Mass spectrometry · 19 Aug 2025 · 21 likes This follows post #40 rather than contradicting it. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not…
-
Travel coolers and how long they really hold Replied, post #39 · Devices › Cold chain · 3 Aug 2025 · 7 likes Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to home if temperatures will be high. Alternatively, time shipment…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #89 · Practice › Reconstitution · 18 Jul 2025 · 6 likes Worth separating two things that post #85 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
Pages past their review date, listed Replied, post #7 · Meta › Wiki maintenance · 17 Jul 2025 · 0 likes Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity. Pointing out redundancy helps maintainers see the issue.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #24 · Clinical › Special populations · 15 Jun 2025 · 0 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #132 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2025 · 3 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Reading a supplier's product description as a marketing document Replied, post #21 · Compounds › Other compounds · 11 May 2025 · 5 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Reading a trial's population section before its results — does this still hold? Replied, post #58 · Evidence › Trials · 1 May 2025 · 0 likes I read post #56 twice before replying, because I had assumed the opposite. The estimand: what the trial set out to estimate. Two trials can be identical in structure…
-
Asking about a compound your prescriber has not heard of Replied, post #8 · Clinical › Prescriber conversations · 31 Mar 2025 · 2 likes Picking up post #5: that is the part I would want checked first. Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit…
-
Units, standards, and other things that quietly hold the world together Replied, post #5 · Lounge › Off topic · 24 Mar 2025 · 12 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #23 · Practice › Interactions · 23 Mar 2025 · 2 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #15 · Practice › Reconstitution · 22 Feb 2025 · 2 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #14 · Compounds › Tirzepatide · 2 Feb 2025 · 0 likes Worth separating two things that post #10 runs together. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #20 · Devices › Syringes & needles · 17 Jan 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
What changed in 2026, by region Replied, post #59 · Access › International · 5 Jan 2025 · 4 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #80 · Compounds › Tirzepatide · 10 Dec 2024 · 10 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Washout with a one-week half-life: the arithmetic Replied, post #18 · Research Methods › N-of-1 designs · 25 Nov 2024 · 6 likes Worth separating two things that post #14 runs together. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #136 · Compounds › Other compounds · 23 Nov 2024 · 31 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Two sessions a week versus four: what the evidence supports Replied, post #7 · Nutrition & Training › Resistance training · 18 Nov 2024 · 0 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
Converting between mg/mL and units per dose, both directions Replied, post #89 · Practice › Reconstitution · 14 Nov 2024 · 12 likes post #88 is right about the mechanism and I think understates the practical bit. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
-
Time to steady state after a dose increase Replied, post #6 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #2 · Clinical › Special populations · 24 Oct 2024 · 7 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #74 · Evidence › Journal club · 15 Oct 2024 · 1 like post #73 answers the question as asked. The question underneath it is different. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #8 · Sourcing › Regulatory · 7 Oct 2024 · 23 likes I read post #6 twice before replying, because I had assumed the opposite. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #61 · Compounds › Semaglutide · 20 Sep 2024 · 22 likes I read post #59 twice before replying, because I had assumed the opposite. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #55 · Nutrition & Training › Hydration & electrolytes · 23 Aug 2024 · 20 likes post #54 is right about the mechanism and I think understates the practical bit. Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #27 · Analytics › Mass spectrometry · 15 Aug 2024 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #135 · Practice › Dosing & titration · 10 Jul 2024 · 7 likes post #134 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…